134 related articles for article (PubMed ID: 37301084)
1. Elevated cerebrospinal fluid YKL-40 levels in patients with anti-gamma-aminobutyric- acid-B receptor encephalitis.
Li J; Wang Y; Xia R; Zhao X; Li L; Wang S
J Neuroimmunol; 2023 Aug; 381():578119. PubMed ID: 37301084
[TBL] [Abstract][Full Text] [Related]
2. Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis.
Chen J; Ding Y; Zheng D; Wang Z; Pan S; Ji T; Shen HY; Wang H
Front Neurol; 2018; 9():727. PubMed ID: 30369903
[No Abstract] [Full Text] [Related]
3. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary infection and baseline mRS scores predict poor prognosis in anti-GABA
Ding J; Xu D; Lv J; Wu T; Li J; Tian M; Lian Y
Front Immunol; 2022; 13():918064. PubMed ID: 36091075
[TBL] [Abstract][Full Text] [Related]
5. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
6. CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis.
Qiao S; Li H; Cui C; Zhang C; Wang A; Jiang W; Zhang S
J Inflamm Res; 2024; 17():1765-1776. PubMed ID: 38523682
[TBL] [Abstract][Full Text] [Related]
7. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and elevated ProGRP and positive oligoclonal bands of 13 Chinese cases with anti-GABABR encephalitis.
Wu H; Wang Y; Wei K; Qiao S; Liu L; Zhang R; Cao L; Wang S; Liu X
Int J Dev Neurosci; 2021 Oct; 81(6):492-501. PubMed ID: 33973258
[TBL] [Abstract][Full Text] [Related]
9. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
Li J; Li H; Wang Y; Zhao X; Wang S; Li L
Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
[TBL] [Abstract][Full Text] [Related]
10. Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands.
Xue H; Guo X; Jiang Y; Qin L; Wang X; Xu J; Zuo S; Liu Q; Li W
Front Neurol; 2023; 14():1281276. PubMed ID: 38249729
[TBL] [Abstract][Full Text] [Related]
11. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
Front Immunol; 2021; 12():680424. PubMed ID: 34220828
[TBL] [Abstract][Full Text] [Related]
12. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
13. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review.
Si Z; Wang A; Liu J; Zhang Z; Hu K
Neurol Sci; 2019 Apr; 40(4):769-777. PubMed ID: 30671737
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
Front Immunol; 2019; 10():103. PubMed ID: 30792710
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis after Japanese encephalitis in children: A prospective study.
Liu B; Liu J; Sun H; Xie M; Yang C; Pan Y; Huang D; Cheng L; Chen H; Ma J; Jiang L
J Neurol Sci; 2021 May; 424():117394. PubMed ID: 33773410
[TBL] [Abstract][Full Text] [Related]
17. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
[TBL] [Abstract][Full Text] [Related]
18. Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.
Alexopoulos H; Akrivou S; Mastroyanni S; Antonopoulou M; Dinopoulos A; Giorgi M; Konstantinou K; Kouremenos E; Lariou M; Naoumis D; Pavlidou E; Pavlou E; Voudris K; Vlachoyiannopoulos P; Dalakas MC
Ther Adv Neurol Disord; 2018; 11():1756286418768778. PubMed ID: 29774053
[TBL] [Abstract][Full Text] [Related]
19. Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABA
Cui D; Feng J; Yang M; Dong Y; Lian Y
Neurol Sci; 2024 Apr; 45(4):1609-1617. PubMed ID: 37940748
[TBL] [Abstract][Full Text] [Related]
20. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
